News

LabReady GBS, an Innovative Women’s Health Diagnostic Device to Improve the Maternal Group B Strep Testing Processes, Is Now Available in Europe

Earlier this week Vax-Immune Diagnostics annoucned that it has received CE Mark approval for its first-in-class medical device, LabReady GBS. LabReady’s Group B Strep product is the first in Vax-Immune Diagnostics’ lineup of women’s health solutions that helps avoid life-threatening complications and expensive consequences for mothers and their babies. With CE Mark approval, LabReady is now available to European physicians, patients, and hospital systems. The brainchild…

Femtech in Europe: Challenges and Opportunities

Every day we get another note about yet another startup, accelerator or European investor eager to break into women’s health innovation. Without question: Femtech in Europe is on the rise and both investors and the media are finally starting to pay attention. And while all this new traction is exciting, there are some unique opportunities, but also challenges the local ecosystem will…

Launched: LaMaria, A New Line of Skincare for Menopausal Women Created by an OB-GYN

Menopause startups are on the rise – both in numbers and in terms of the capital and attention they attract. Today another company focused on menopausal women joins their ranks: LaMaria – A skincare brand that’s pro-you instead of anti-age. The DTC company was founded by OB-GYN Dr. Manuela Maria Vazquez who wanted to create a product specifically for women undergoing hormonal…

Femtech Startup Nest Collaborative Announces a $2.1M Seed Round to Scale Its Virtual Lactation Consultation Platform

Today Nest Collaborative, the creator of the first virtual lactation consultation platform, announced a $2.1M seed round led by Altitude Ventures, a healthcare-focused venture capital fund to scale its offering. Other investors participating in the round include Bread and Butter Ventures, Wavemaker 360, Portfolia FemTech Fund II, Connecticut Innovations, Carnrite Ventures, and the Hustle Fund. “More than 3 million mothers in the…

Evofem Launches Its First DTC Advertising Campaign to Accelerate Awareness of Phexxi, Its Non-Hormonal Birth Control Option for Women

Earlier today Evofem announced the launch of “Get Phexxi”, a national direct-to-consumer campaign aimed at broadening awareness of its non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi Approved by the U.S. Food and Drug Administration (FDA) in May 2020, Phexxi is an innovative non-hormonal contraceptive method created for women.  With 21 million women in the U.S. at risk for pregnancy who are NOT using hormonal contraception, the company feels the time is…

Women’s Reproductive Health Startup Ava Announces FDA Clearance for Ava Fertility Tracker

Ava, a digital healthcare company focused on women’s reproductive health, announced today it has received FDA clearance for its Ava Fertility Tracker, making it the first and only FDA-cleared fertility tracking wearable.   A fertility tracking sensor bracelet and accompanying app, Ava Fertility Tracker is already the first and only wearable, machine learning device to aid women in ovulation prediction and facilitation of…

The American Board of Obstetrics and Gynecology (ABOG) Announces the Appointment of Three New Board of Directors Members

The American Board of Obstetrics and Gynecology (ABOG) has recently announced the appointment of three new subspecialty Division Chairs and four new Division Members. They all will begin their terms on July 1, 2021. The Chairs will also serve as ex-officio subspecialty representatives on the Board of Directors.  The American Board of Obstetrics and Gynecology (ABOG) is an independent, non-profit organization that certifies obstetricians and gynecologists in the United States. Founded in 1927, ABOG…

Spain-based Endometrial Cancer Diagnostics Company MiMark Receives €1.5M Investment from EIT Health

Barcelona-based company MiMARK has received €1.5M in funding from EIT Health following the EIT Health Wild Card program. The company is working on improving accuracy and efficiency of diagnostics for endometrial cancer. Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological…